{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:30:29Z","timestamp":1787236229800,"version":"build-2736575974"},"reference-count":51,"publisher":"Asia Pacific Academy of Ophthalmology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia Pac J Ophthalmol (Phila)"],"published-print":{"date-parts":[[2019]]},"DOI":"10.22608\/apo.2018293","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T07:23:22Z","timestamp":1531466602000},"source":"Crossref","is-referenced-by-count":9,"title":["Leber Hereditary Optic Neuropathy\u2014Light at the End of the Tunnel?"],"prefix":"10.22608","member":"9895","published-online":{"date-parts":[[2019]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"Yu-Wai-Man","year":"2009","unstructured":"1. Yu-Wai-Man P, Griffiths PG, Hudson G, et al. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145\u2013158.","journal-title":"J Med Genet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrneurol.2012.167","article-title":"Treatment of hereditary optic neuropathies","volume":"8","author":"Newman","year":"2012","unstructured":"2. Newman NJ. Treatment of hereditary optic neuropathies. Nat Rev Neurol. 2012;8:545\u2013556.","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","unstructured":"3. Yu-Wai-Man P, Votruba M, Moore AT, et al. Treatment strategies for inherited optic neuropathies: past, present and future. Eye (Lond). 2014;28:521\u2013537.","journal-title":"Eye (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Yu-Wai-Man","year":"2003","unstructured":"4. Yu-Wai-Man P, Griffiths PG, Brown DT, et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72:333\u2013339.","journal-title":"Am J Hum Genet"},{"key":"ref4","first-page":"939","article-title":"Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees.","volume":"49","author":"Howell","year":"1991","unstructured":"5. Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet. 1991;49:939\u2013950.","journal-title":"Am J Hum Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9297","issn-type":"print"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","unstructured":"6. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427\u20131430.","journal-title":"Science"},{"key":"ref6","first-page":"1165","article-title":"Leber hereditary optic neuropathy: current perspectives.","volume":"9","author":"Meyerson","year":"2015","unstructured":"7. Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165\u20131176.","journal-title":"Clin Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/1177-5467","issn-type":"print"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","unstructured":"8. Kirkman MA, Korsten A, Leonhardt M, et al. Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112\u20133115.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders.","author":"Pfeffer","year":"2012","unstructured":"9. Pfeffer G, Majamaa K, Turnbull DM, et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev. 2012:CD004426.","journal-title":"Cochrane Database Syst Rev","ISSN":"https:\/\/id.crossref.org\/issn\/1469-493X","issn-type":"print"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.bbabio.2006.05.007","article-title":"Mitochondrial complex I: structural and functional aspects","volume":"1757","author":"Lenaz","year":"2006","unstructured":"10. Lenaz G, Fato R, Genova ML, et al. Mitochondrial complex I: structural and functional aspects. Biochim Biophys Acta. 2006;1757:1406\u20131420.","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mito.2017.01.004","article-title":"Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy","volume":"36","author":"Yu-Wai-Man","year":"2017","unstructured":"11. Yu-Wai-Man P, Soiferman D, Moore DG, et al. Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy. Mitochondrion. 2017;36:36\u201342.","journal-title":"Mitochondrion"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","unstructured":"12. Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain. 2011;134:2677\u20132686.","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy.","volume":"134","author":"Carelli","year":"2011","unstructured":"13. Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain. 2011;134:e188.","journal-title":"Brain","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8950","issn-type":"print"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICU.0000000000000410","article-title":"Leber hereditary optic neuropathy: bridging the translational gap","volume":"28","author":"Jurkute","year":"2017","unstructured":"14. Jurkute N, Yu-Wai-Man P. Leber hereditary optic neuropathy: bridging the translational gap. Curr Opin Ophthalmol. 2017;28:403\u2013409.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","article-title":"International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy","volume":"37","author":"Carelli","year":"2017","unstructured":"15. Carelli V, Carbonelli M, de Coo IF, et al. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37:371\u2013381.","journal-title":"J Neuroophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","unstructured":"16. Sadun AA, Chicani CF, Ross-Cisneros FN, et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol. 2012;69:331\u2013338.","journal-title":"Arch Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1212","DOI":"10.1212\/WNL.0000000000005255","article-title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.","volume":"90","author":"Karaa","year":"2018","unstructured":"17. Karaa A, Haas R, Goldstein A, et al. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. Neurology. 2018;90:e1212\u2013e1221.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatments for mitochondrial disease-no time to drop our standards","volume":"9","author":"Pfeffer","year":"2013","unstructured":"18. Pfeffer G, Horvath R, Klopstock T, et al. New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol. 2013;9:474\u2013481.","journal-title":"Nat Rev Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","article-title":"Gene-environment interactions in Leber hereditary optic neuropathy","volume":"132","author":"Kirkman","year":"2009","unstructured":"19. Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132:2317\u20132326.","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.01.042","article-title":"A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function","volume":"319","author":"Smith","year":"2016","unstructured":"20. Smith TG, Seto S, Ganne P, et al. A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function. Neuroscience. 2016;319:92\u2013106.","journal-title":"Neuroscience"},{"key":"ref20","first-page":"6921","article-title":"Targeting estrogen receptor beta as preventive therapeutic strategy for Leber's hereditary optic neuropathy.","volume":"24","author":"Pisano","year":"2015","unstructured":"21. Pisano A, Preziuso C, Iommarini L, et al. Targeting estrogen receptor beta as preventive therapeutic strategy for Leber's hereditary optic neuropathy. Hum Mol Genet. 2015;24:6921\u20136931.","journal-title":"Hum Mol Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0964-6906","issn-type":"print"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","unstructured":"22. Giordano C, Iommarini L, Giordano L, et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy. Brain. 2014;137:335\u2013353.","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e2021","DOI":"10.1038\/cddis.2015.364","article-title":"Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways.","volume":"6","author":"Giordano","year":"2015","unstructured":"23. Giordano L, Deceglie S, d'Adamo P, et al. Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis. 2015;6:e2021.","journal-title":"Cell Death Dis","ISSN":"https:\/\/id.crossref.org\/issn\/2041-4889","issn-type":"print"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","unstructured":"24. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240\u20132248.","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","unstructured":"25. MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet. 2014;383:1129\u20131137.","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/bjophthalmol-2015-308329","article-title":"Genetic manipulation for inherited neurodegenerative diseases: myth or reality?","volume":"100","author":"Yu-Wai-Man","year":"2016","unstructured":"26. Yu-Wai-Man P. Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol. 2016;100:1322\u20131331.","journal-title":"Br J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1161","issn-type":"print"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ng851","article-title":"Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus","volume":"30","author":"Manfredi","year":"2002","unstructured":"27. Manfredi G, Fu J, Ojaimi J, et al. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet. 2002;30:394\u2013399.","journal-title":"Nat Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy","volume":"52","author":"Guy","year":"2002","unstructured":"28. Guy J, Qi X, Pallotti F, et al. Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol. 2002;52:534\u2013542.","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1167\/iovs.08-3214","article-title":"Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system","volume":"50","author":"Guy","year":"2009","unstructured":"29. Guy J, Qi X, Koilkonda RD, et al. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. Invest Ophthalmol Vis Sci. 2009;50:4205\u20134214.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","unstructured":"30. Ellouze S, Augustin S, Bouaita A, et al. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet. 2008;83:373\u2013387.","journal-title":"Am J Hum Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","article-title":"Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial","volume":"132","author":"Koilkonda","year":"2014","unstructured":"31. Koilkonda RD, Yu H, Chou TH, et al. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132:409\u2013420.","journal-title":"JAMA Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","unstructured":"32. Yang S, Ma SQ, Wan X, et al. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. EBioMedicine. 2016;10:258\u2013268.","journal-title":"EBioMedicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene therapy for Leber hereditary optic neuropathy: low- and medium-dose visual results","volume":"124","author":"Guy","year":"2017","unstructured":"33. Guy J, Feuer WJ, Davis JL, et al. Gene therapy for Leber hereditary optic neuropathy: low- and medium-dose visual results. Ophthalmology. 2017;124:1621\u20131634.","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ophtha.2017.12.036","article-title":"Safety of rAAV2\/2-ND4 gene therapy for Leber hereditary optic neuropathy","volume":"125","author":"Vignal","year":"2018","unstructured":"34. Vignal C, Uretsky S, Fitoussi S, et al. Safety of rAAV2\/2-ND4 gene therapy for Leber hereditary optic neuropathy. Ophthalmology. 2018;125:945\u2013947.","journal-title":"Ophthalmology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/nar\/gkq769","article-title":"Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task?","volume":"39","author":"Perales-Clemente","year":"2011","unstructured":"35. Perales-Clemente E, Fernandez-Silva P, Acin-Perez R, et al. Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task? Nucleic Acids Res. 2011;39:225\u2013234.","journal-title":"Nucleic Acids Res","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1048","issn-type":"print"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMcibr1608715","article-title":"Mitochondrial matchmaking","volume":"375","author":"PF","year":"2016","unstructured":"36. Chinnery PF, Zeviani M. Mitochondrial matchmaking. N Engl J Med. 2016;375:1894\u20131896.","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature18303","article-title":"Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease","volume":"534","author":"Hyslop","year":"2016","unstructured":"37. Hyslop LA, Blakeley P, Craven L, et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature. 2016;534:383\u2013386.","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature20592","article-title":"Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations","volume":"540","author":"Kang","year":"2016","unstructured":"38. Kang E, Wu J, Gutierrez NM, et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature. 2016;540:270\u2013275.","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1004315","DOI":"10.1371\/journal.pgen.1004315","article-title":"The challenges of mitochondrial replacement.","volume":"10","author":"Chinnery","year":"2014","unstructured":"39. Chinnery PF, Craven L, Mitalipov S, et al. The challenges of mitochondrial replacement. PLoS Genet. 2014;10:e1004315.","journal-title":"PLoS Genet","ISSN":"https:\/\/id.crossref.org\/issn\/1553-7390","issn-type":"print"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2017.08.009","article-title":"Mitochondrial replacement techniques: remaining ethical challenges","volume":"21","author":"AL","year":"2017","unstructured":"40. Bredenoord AL, Appleby JB. Mitochondrial replacement techniques: remaining ethical challenges. Cell Stem Cell. 2017;21:301\u2013304.","journal-title":"Cell Stem Cell"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/ojls\/gqx012","article-title":"Germline genetic modification and identity: the mitochondrial and nuclear genomes","volume":"37","author":"Scott","year":"2017","unstructured":"41. Scott R, Wilkinson S. Germline genetic modification and identity: the mitochondrial and nuclear genomes. Oxf J Leg Stud. 2017;37:886\u2013915.","journal-title":"Oxf J Leg Stud"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.15252\/embr.201439110","article-title":"Risks inherent to mitochondrial replacement","volume":"16","author":"Morrow","year":"2015","unstructured":"42. Morrow EH, Reinhardt K, Wolff JN, et al. Risks inherent to mitochondrial replacement. EMBO Rep. 2015;16:541\u2013544.","journal-title":"EMBO Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.rbmo.2017.02.004","article-title":"First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation","volume":"34","author":"Alikani","year":"2017","unstructured":"43. Alikani M, Fauser BCJ, Garcia-Valesco JA, et al. First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation. Reprod Biomed Online. 2017;34:333\u2013336.","journal-title":"Reprod Biomed Online"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","volume":"34","author":"Zhang","year":"2017","unstructured":"44. Zhang J, Liu H, Luo S, et al. Corrigendum to 'Live birth derived from oocyte spindle transfer to prevent mitochondrial disease': [Reproductive BioMedicine Online 34 (2017) 361\u2013368]. Reprod Biomed Online. 2017;35:49.","journal-title":"[Reproductive BioMedicine Online"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMc1500960","article-title":"Mitochondrial donation--how many women could benefit?","volume":"372","author":"Gorman","year":"2015","unstructured":"45. Gorman GS, Grady JP, Turnbull DM. Mitochondrial donation--how many women could benefit? N Engl J Med. 2015;372:885\u2013887.","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.15252\/emmm.201606281","article-title":"Ethical and legal issues in mitochondrial transfer","volume":"8","author":"Newson","year":"2016","unstructured":"46. Newson AJ, Wilkinson S, Wrigley A. Ethical and legal issues in mitochondrial transfer. EMBO Mol Med. 2016;8:589\u2013591.","journal-title":"EMBO Mol Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","unstructured":"47. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u2013676.","journal-title":"Cell"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.18632\/aging.100950","article-title":"Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells","volume":"8","author":"Hung","year":"2016","unstructured":"48. Hung SS, Van Bergen NJ, Jackson S, et al. Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells. Aging (Albany NY). 2016;8:945\u2013957.","journal-title":"Aging (Albany NY)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.18632\/aging.101231","article-title":"Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy.","volume":"9","author":"Wong","year":"2017","unstructured":"49. Wong RCB, Lim SY, Hung SSC, et al. Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy. Aging (Albany NY). 2017;9:1341\u20131350.","journal-title":"Aging (Albany NY)","ISSN":"https:\/\/id.crossref.org\/issn\/1945-4589","issn-type":"print"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1038\/srep08344","article-title":"Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells","volume":"5","author":"Tanaka","year":"2015","unstructured":"50. Tanaka T, Yokoi T, Tamalu F, et al. Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells. Sci Rep. 2015;5:8344.","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"13. Chamling X, Sluch VM, Zack DJ. The potential of human stem cells for the study and treatment of glaucoma. Invest Ophthalmol Vis Sci. 2016;57:ORSFi1\u2013ORSFi6.","DOI":"10.1167\/iovs.15-18590"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T15:36:20Z","timestamp":1571585780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/apjoo\/Fulltext\/2018\/07000\/Leber_Hereditary_Optic_Neuropathy_Light_at_the_End.5.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":51,"URL":"https:\/\/doi.org\/10.22608\/apo.2018293","relation":{},"ISSN":["2162-0989","2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"},{"value":"2162-0989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}